Reno-protective effects of oral alkalizing agents in chronic kidney disease with aciduria: protocol for a randomized cohort study

BACKGROUND: Aciduria caused by urinary excretion of acidic metabolic wastes produced in daily life is known to be augmented in patients with chronic kidney disease (CKD). To evaluate the reno-protective effect of oral alkalizing agents for the improvement of metabolic acidosis and neutralization of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Nephrol
Päätekijät: Abe, Michiaki, Akaishi, Tetsuya, Shoji, Mutsumi, Yamaguchi, Takuhiro, Miki, Takashi, Satoh, Fumitoshi, Takayama, Shin, Yamasaki, Satomi, Kawaguchi, Kazuhiko, Sato, Hiroshi, Ishii, Tadashi, Ito, Sadayoshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7178750/
https://ncbi.nlm.nih.gov/pubmed/32321450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-01807-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia